- Home
- VCYT vs EROC Comparison
VCYT vs EROC Comparison
Compare VCYT & EROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$51.41
Company Overview
Basic Information| Metric | VCYT | EROC |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 2013 | 2026 |
Fundamental Metrics
Financial Performance| Metric | VCYT | EROC |
|---|---|---|
| Price | $51.41 | N/A |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $44.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | N/A |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.76 | N/A |
| Revenue Next Year | $12.35 | N/A |
| P/E Ratio | $145.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.61 | N/A |
| 52 Week High | $52.45 | N/A |
Technical Indicators
Market Signals| Indicator | VCYT | EROC |
|---|---|---|
| Relative Strength Index (RSI) | 68.75 | N/A |
| Support Level | $40.27 | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 2.41 | 0.00 |
| MACD | -0.11 | 0.00 |
| Stochastic Oscillator | 80.07 | 0.00 |
Price Performance
Historical Comparison VCYT
EROC
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).